Articles

The investment is intended for the Halo Pharma facility in Whippany, NJ, and aims to help relieve capacity shortages in the injectable supply chain in the United States.

Noramco Group Establishes Sterile Injectable Manufacturing Capabilities with $25 Million Investment

Felicity Thomas is the former Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Videos

Pharmaceutical Technology® chats with Miguel Forte from ISCT and Kiji Therapeutics about expectations for 2025 and the future technology agenda for industry.

Industry Outlook 2025: Setting the Tone for Industry

Supporting the prosperity of women in science fields benefits the bio/pharmaceutical industry.

International Women’s Day 2025: Celebrating Women in Science

Gender diversity and equality in leadership positions have been shown to improve profitability and return on equity through greater innovation and more creative solutions. 

International Women’s Day 2025: Improving Innovation in Industry

In an interview with Pharmaceutical Technology®, Sheryl Johnson from Orbia Fluor & Energy Materials chats about gender diversity, how women are helping to advance innovation, sustainability challenges, and progress in the field of inhaled drugs.

International Women’s Day 2025: A Promising Future for Gender Diversity in Pharma

The €4 million (US$4.3 million) project is current good manufacturing practice compliant, and includes an accompanying cartoning machine.

Adragos Pharma Completes Liquid Filling Line Installation in Germany

The detector features specialized, solid-state dual infrared (IR) sources and dual IR receivers which provide continual cross-checks and internal adjustments to adhere to factory calibration.

Emerson Releases Fixed Point Gas Detector Cutting Down on False Alarms

The alterations are the result of an agency review of findings from a clinical trial, and data from required postmarket studies.

FDA Makes Class-Wide Labeling Changes to Testosterone Products

In an interview with Pharmaceutical Technology®, Miguel Forte from ISCT and Kiji Therapeutics provides his insights into the M&A landscape from 2024 and his expectations of what is to come next.

Industry Outlook 2025: Looking at the Investment Environment

The company said this blender supports applications for which either stainless steel or carbon steel may not be suitable.

News